Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.25
BATS BZX Real-Time Price
As of 3:37pm ET
 -0.02 / -1.57%
Today’s Change
1.13
Today|||52-Week Range
4.62
-54.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues47.8M102.8M89.3M144.3M
 
 
 
 
 
Cost of Goods Sold----46.0K2.7M
 
 
 
Depreciation And Amortization2.6M3.2M4.3M7.9M
 
 
 
 
 
 
Operating ExpensesGross Income----84.9M133.7M
 
 
 
General Expenses164.9M165.8M214.5M231.5M
 
 
 
 
 
Other Operating Expenses0.000.000.003.6M
 
 
Research And Development146.3M138.5M161.0M158.1M
 
 
 
 
 
Total Operating Expenses167.5M169.0M218.8M245.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-119.7M-66.3M-129.6M-101.5M
 
 
 
 
 
Extraordinary Charge-800.0K0.000.00-23.2M
 
 
 
Interest Expense On Debt10.9M18.2M19.2M29.1M
 
 
 
 
 
Other Expenses627.0K813.0K917.0K-8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-130.7M-83.6M-147.8M-153.5M
 
 
 
 
 
Minority Interest-240.0K-268.0K-170.0K-1.8M
 
 
 
 
 
Net Income-130.9M-83.3M-148.0M-151.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.9M104.4M111.4M125.3M
 
 
 
 
 
Shares To Calculate EPS Diluted98.9M104.4M111.4M125.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.32-$0.80-$1.33-$1.21
 
 
 
 
 
EPS Diluted-$1.32-$0.80-$1.33-$1.21